Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, academic) - Global Forecast to 2029

The Cell Culture Market is expected to reach $48.63 billion by 2029, at a CAGR of 11.7% from 2022 to 2029.

The cell culture market comprises various consumables and equipment required at different stages of the cell culture technique to understand the basic biology and biochemistry of cells. It acts as a model system and can be used for various applications such as bioproduction, cancer research, stem cell research, diagnostics, and drug screening.

The growth of this market is driven by factors such as the growth in biopharmaceutical market, increasing prevalence of chronic diseases, growing demand for monoclonal antibodies, increase in research funding, and rising adoption of single-use technologies. However, disposal of plastic waste generated from single-use technologies, cell line misidentification, and cross-contamination hamper the growth of this market to a notable extent.

The Impact of the COVID-19 Pandemic: Collaboration Strategy Increased the Usage of Cell Culture Products

Major pharmaceutical and biotech companies collaborated to find vaccines and treatment methods during the pandemic. The idea behind the collaboration was to come together and find a solution as quickly as possible during the pandemic, which could not be possible alone. Collaborations also took place within companies and universities to speed up the research and production process. Outsourcing pharmaceutical and biotechnological research to contract research organizations (CROs) also increased during the pandemic. Below are some of the instances:

• In 2022, GlaxoSmithKline plc (U.K.) and Vir Biotechnology, Inc. (U.S.) announced the supply of Sotrovimab to the U.S. government for the early treatment of COVID-19. Sotrovimab, a monoclonal antibody, was granted emergency use authorization (EUA) by the U.S. FDA in May 2021.
• In May 2020, four CROs, which included Charnwood Molecular LTD (U.K.), Reach Separations (U.K.), XenoGesis (U.K.), and Aurelia Bioscience Ltd (U.K.), built a shared initiative to continue with their COVID-19 therapeutic research activity.
• In April 2020, AstraZeneca plc (U.K.) and Oxford Biomedica plc (U.K.) signed an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine, wherein the development and worldwide manufacturing and distribution of the vaccine was the responsibility of AstraZeneca
• In March 2020, Eli Lilly and Company (U.S.) collaborated with AbCellera Biologics Inc. (Canada) on a COVID-19 antibody treatment. The two companies utilized AbCellera’s rapid pandemic response platform to develop and manufacture therapeutic antibodies.
• In March 2020, Mount Sinai Health System (U.S.) and Harbour BioMed (Hong Kong) signed a multi-year collaboration and utilized the H2L2 Harbour Mice platform to develop antibodies against the SARS-CoV-2.

Hence, the growing collaborations in the pharma sector for research and development for drug manufacturing increased the usage of cell culture products.

Click here to: Get Free Sample Copy of this report

Funding for Cell-based Research Drive Market Growth

Cell-based research studies help understand cells' responses to any chemical and identify novel components that can be used for people's well-being. Additionally, these studies are continued for a long time as standardization is needed when finding novel therapies. Such studies require investments that further support innovations in the medical field. For instance:

• In December 2021, Novo Nordisk Foundation granted up to USD 355 million (300 million euros) for establishing an international research center focused on stem cell medicine. The center is a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands. The partnership between these three research institutions will lead to innovative stem cell-based treatments.
• In June 2021, the Morrison Government announced an investment of USD 180 million in medical research projects around Australia to improve healthcare. 106 medical research projects, including studies regarding cancer, dementia, brain injuries, heart problems, and neurofibromatosis, are likely to receive USD 20 billion Medical Research Future Fund. USD 18.7 million will be provided through the Stem Cell Mission for 17 projects addressing illnesses including heart disease, COVID-19, epilepsy, and childhood cancer.
• In November 2020, the Canadian Institutes of Health Research announced an investment of more than USD 30 million over the next seven years, starting from 2020–2021, in a new research project, which is a part of the ‘100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes’ initiative. This will accelerate the development of stem cell-based therapies for treating Type 1 diabetes.

These investments and support for cell-based research activities drive the demand for cell culture products.

Key Findings of the Cell Culture Market Study:

The Consumables Segment to Dominate the Cell Culture Market in 2022

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The frequent use of cell culture consumables such as media, reagents, and sera in large quantities for various applications supports this segment's large market share. Due to its usage in various applications, new formulations in the cell culture media are also being developed for precise cell culturing.

The Bioproduction Segment to Dominate the Cell Culture Market in 2022

Based on application, in 2022, the bioproduction segment is estimated to account for the largest share of the cell culture market. The major factors contributing to the large market share of this segment are the consumption of cell culture products for research and commercial bioproduction, the increasing demand for pharma and biopharma products, and the availability of funds for carrying out research activities.

The Pharmaceutical & Biotechnology Companies Segment to Dominate Cell Culture Market in 2022

Based on end user, in 2022, the pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the cell culture market. Factors driving the large market share of this segment are the high consumption of cell culture products in commercial and research bioproduction and relatively greater purchasing power than other end users.

Asia-Pacific: Fastest-growing Regional Market

Based on geography, Asia-Pacific is expected to register the highest growth rate during the forecast period. The growth of this regional market is driven by the growing recognition of the region as a major outsourcing destination for pharmaceuticals & biopharmaceuticals companies, rapidly developing economies, and growing aging population coupled with the rising prevalence of chronic diseases and developing research infrastructure in this region.

Key Players

The key players profiled in the cell culture market study are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden),  Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V. & Co. KG (Germany).

Scope of the Report:

Cell Culture Market, by Product

• Consumables
  • Media
    • Form
      • Dry Form
      • Liquid Form
    • Type
      • Off-the-Shelf Media
      • Custom Media
    • Source
      • Serum-free Media
      • Chemically Defined Media
      • Classical Media
      • Xeno-free/Animal Component Free
  • Reagents
    • Growth Factors and Cytokines
    • Cryoprotective Reagents
    • Antibiotics/Antimycotics
    • Cell Dissociation Reagents
    • Buffers
    • Balanced Salt Solutions
    • Attachment and Matrix Factors
    • Other Cell Culture Reagents
      (Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains, and dyes)
  • Cells and Cell Lines
  • Sera
    • Fetal Bovine Serum
    • Other Sera Types
      (Other sera include newborn calf serum, chicken serum, goat serum, rabbit serum, pig serum, mouse serum, sheep serum, rat serum, and horse serum)
  • Cell Culture Vessels
    • Cell Culture Dishes
    • Cell Culture Plates
      • 6 to 24-well Plates
      • 48-well Plates
      • 96 to 384-well Plates
    • Cell Culture Flasks
    • Roller Bottles
    • Other Cell Culture Vessels
      (Other cell culture vessels include pipettes, tips, cuvettes, and tubings)
• Equipment
  • Bioreactors
  • Biosafety Cabinets
  • Incubators
  • Cryopreservation Containers
  • Refrigerators and Freezers
  • Sterilizers
  • Microscopes
  • Centrifuges
  • Cell Counters
  • Water Baths
  • Other Equipment
    (Other equipment includes scales, weighing balance, and pH meter)

Cell Culture Market, by Application

• Bioproduction
  • Monoclonal Antibody Production
  • Therapeutic Protein Production
  • Vaccine Production
  • Cell and Gene therapy
• Drug Screening & Development
• Cancer Research
• Stem Cell Research
• Other Applications

Cell Culture Market, by End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Other End Users

Cell Culture Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Key questions answered in the report: